Nightingale Health Plc – Managers’ transactions – 29 November 2022 9:45 a.m. (EET)

____________________________________________

Person subject to the notification requirement

Name: Kaikarhenni Oy

Position: Member of the Board/Deputy member

(X) Legal person

(1):Person Discharging Managerial Responsibilities In Issuer

Name: Leena Niemistö

Position: Member of the Board

Issuer: Nightingale Health Plc

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 21425/4/5

____________________________________________

Transaction date: 2022-11-25

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

(X) Executed under portfolio or asset management

Transaction details

(1): Volume: 74,074 Unit price: 1.164 EUR

Aggregated transactions

(1): Volume: 74,074 Volume weighted average price: 1.164 EUR

The purpose of the transaction

Board member Leena Niemistö transferred 74,074 series B shares held by her in Nightingale Health Plc to Kaikarhenni Oy, a company under her control.

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com, tel. +358 20 730 1810

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale Health

Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.